Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
20
Frequently Asked Questions
What is Market Cap of Kitov Pharma Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kitov Pharma Ltd - ADR market cap is $12.74M.
What is the 52-week high for Kitov Pharma Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kitov Pharma Ltd - ADR 52 week high is $2.08 as of October 10, 2025.
What is the 52-week low for Kitov Pharma Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kitov Pharma Ltd - ADR 52 week low is $0.3023 as of October 10, 2025.
What is Kitov Pharma Ltd - ADR stock price today?
Kitov Pharma Ltd - ADR stock price today is $0.5002.
What was Kitov Pharma Ltd - ADR stock price yesterday?
Kitov Pharma Ltd - ADR stock price yesterday was $0.49.
What is the PE ratio of Kitov Pharma Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kitov Pharma Ltd - ADR’s P/E ratio is -0.54.
What is the Price-to-Book ratio of Kitov Pharma Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kitov Pharma Ltd - ADR P/B ratio is 0.3527.
What is Kitov Pharma Ltd - ADR's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Kitov Pharma Ltd - ADR's EBITDA is -0.19.
What is the 50-day moving average of Kitov Pharma Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kitov Pharma Ltd - ADR 50-day moving average is $0.6698.
How many employess does Kitov Pharma Ltd - ADR has?
